Publication | Closed Access
Clinical Activity of Sorafenib and Sunitinib in Renal Cell Carcinoma Refractory to Previous Vascular Endothelial Growth Factor–Targeted Therapy: Two Case Reports
15
Citations
7
References
2006
Year
UrologyAngiogenesisGenitourinary CancerMedicineCase ReportsCancer TreatmentOncologyRadiation OncologyClinical ActivityCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1